Published in Int J Urol on May 18, 2011
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice. Endocr Relat Cancer (2006) 2.04
Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial. Int J Urol (2012) 1.62
Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol (2005) 1.62
Ejaculatory duct obstruction caused by a right giant seminal vesicle with an ipsilateral upper urinary tract agenesia: an embryologic malformation. Fertil Steril (2007) 1.59
Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction. PLoS One (2012) 1.44
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. Int J Oncol (2007) 1.03
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology (2005) 1.01
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. Endocr Relat Cancer (2009) 0.95
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate (2004) 0.94
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost (2005) 0.93
Development and validation of an ELISA method for detection of growth arrest specific 6 (GAS6) protein in human plasma. J Immunoassay Immunochem (2008) 0.93
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways. Anticancer Drugs (2006) 0.91
May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for varicocele? World J Urol (2007) 0.91
Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients. Urol Oncol (2012) 0.91
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer. Endocr Relat Cancer (2007) 0.89
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro. Int J Cancer (2005) 0.89
Bladder outlet obstruction index and maximal flow rate during urodynamic study as powerful predictors for the detection of urodynamic obstruction in women. Neurourol Urodyn (2007) 0.89
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors. Prostate (2008) 0.89
Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study. J Sex Med (2008) 0.88
Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement. Exp Cell Res (2002) 0.88
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells. Eur J Cancer (2006) 0.88
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells. Endocr Relat Cancer (2008) 0.87
Oxidative stress in benign prostatic hyperplasia and prostate cancer. Urol Int (2010) 0.86
Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health. Menopause (2009) 0.86
Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells. Prostate (2008) 0.86
Penile rehabilitation therapy following radical prostatectomy. Disabil Rehabil (2010) 0.86
Intrascrotal Abscess, Propionibacterium acnes and Staphylococcus cohnii ssp. cohnii: A Case Report and Review of the Literature. Case Rep Urol (2012) 0.85
Cavoatrial tumor thrombectomy with systemic circulatory arrest and antegrade cerebral perfusion. Ann Thorac Surg (2007) 0.85
Evaluation of metastatic potential in prostate carcinoma: an in vivo model. Int J Oncol (2004) 0.85
Retroperitoneal cysts: a case report. Arch Ital Urol Androl (2006) 0.85
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells. Oncol Rep (2007) 0.84
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer. Diagn Pathol (2011) 0.84
Urgent ureteroscopy as first-line treatment for ureteral stones: a meta-analysis of 681 patients. Urol Res (2012) 0.83
The role of left superior parietal lobe in male sexual behavior: dynamics of distinct components revealed by FMRI. J Sex Med (2012) 0.83
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells. Int J Oncol (2004) 0.82
Prognostic value of total atrial conduction time measured with tissue Doppler imaging to predict the maintenance of sinus rhythm after external electrical cardioversion of persistent atrial fibrillation. Echocardiography (2014) 0.82
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression. BMC Cancer (2014) 0.82
Estimating excess glucose, sodium and water deficits in non-ketotic hyperglycaemia. Nephrol Dial Transplant (2007) 0.82
Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer. Int Braz J Urol (2011) 0.81
Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis? J Urol (2007) 0.81
Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism. Respir Med (2008) 0.80
Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Int J Oncol (2008) 0.80
Bicalutamide demonstrates biologic effectiveness in prostate cancer cell lines and tumor primary cultures irrespective of Her2/neu expression levels. Urology (2009) 0.80
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma. Prostate (2007) 0.79
Measurement of the thickness of the urethrovaginal space in women with or without orgasm: a rebuttal. J Sex Med (2008) 0.79
Checklists: Are really necessary in the routinely clinical practice? Int J Surg (2012) 0.79
Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer. Urology (2007) 0.79
Has the cost of anti-muscarinic a key role in the success rate of patients diagnosed with overactive bladder syndrome? Arch Ital Urol Androl (2012) 0.78
PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study. World J Urol (2010) 0.78
Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma. Prostate (2008) 0.77
Haemostatics in surgery and our experience in the enucleoresection of renal cell carcinoma. World J Surg Oncol (2010) 0.77
In vitro study of Human Dermal Fibroblasts seeded on two kinds of surgical meshes: monofilamented Polypropylene and multifilamented Polyestere. Ital J Anat Embryol (2004) 0.77
Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment. Prostate (2009) 0.77
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients. Oncol Rep (2007) 0.76
[Impacts of antibiotic and anti-inflammatory therapy on serum prostate specific antigen in asymptomatic men: our experience]. Urologia (2012) 0.76
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples. Int J Oncol (2005) 0.76
Behavioral interventions for incontinence and other urinary symptoms: more than pelvic muscle exercises. J Urol (2010) 0.75
New method to compute mixed water and electrolyte changes in hyponatremia: a preliminary report. J Nephrol (2009) 0.75
Sarcoma of prostate: case report and review of the literature. Arch Ital Urol Androl (2010) 0.75
[An unusual case of massive funicular lipoma]. Urologia (2013) 0.75
An improved method to compute the solute and water derangements of hyperglycaemia. Eur J Appl Physiol (2007) 0.75
Hyperosmolar coma due to exclusive glucose accumulation: recognition and computations. Nephrology (Carlton) (2009) 0.75
Use of transvaginal ultrasound in females with primary bladder neck obstruction. A preliminary study. Arch Ital Urol Androl (2015) 0.75
Bilateral megaureter: management strategy in a ninety years old woman. Arch Ital Urol Androl (2007) 0.75
[Herbs and cardiotoxic effects]. G Ital Cardiol (Rome) (2013) 0.75
Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity. Neurourol Urodyn (2009) 0.75
Role of echocardiographic dyssynchrony parameters in predicting response to cardiac resynchronization therapy. J Cardiovasc Med (Hagerstown) (2015) 0.75
[Impact of overactive bladder on sexual function in women]. Urologia (2011) 0.75
BPH/LUTS and ED: common pharmacological pathways for a common treatment. J Sex Med (2013) 0.75
An innovative combined antero-retrograde approach for the resolution of the complete iatrogenic obliteration of ureteral ostium: a case report. Arch Ital Urol Androl (2012) 0.75
Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386. J Urol (2008) 0.75
Isolated supravalvular pulmonary stenosis: a rare echocardiographic finding. Echocardiography (2014) 0.75
Periprostatic nerve block before ultrasound-guided prostate biopsy: a comparison of two local anesthetics. Arch Ital Urol Androl (2009) 0.75
Low-Dose Intravaginal Estriol and Pelvic Floor Rehabilitation in Post-Menopausal Stress Urinary Incontinence. Urol Int (2015) 0.75
PSA supernormalisation: a surrogate of complete adenoma removal in men with benign prostatic hyperplasia. Arch Ital Urol Androl (2010) 0.75
Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models. Arch Ital Urol Androl (2011) 0.75
A refined combined antero-retrograde approach for the resolution of a complex ureterovaginal fistula: an endourologic case report. Urologia (2013) 0.75
Does transrectal color Doppler ultrasound improve the diagnosis of prostate cancer? Arch Ital Urol Androl (2012) 0.75
TURP in the young man: is it possible to preserve the anterograde ejaculation? Urologia (2013) 0.75
[Imaging of medullary sponge kidney: notes for urologists]. Urologia (2014) 0.75
Modulating the inflammatory response to provide the best environment for healing in the pelvic organ prolapse (POP) repair A preliminary study using coated medical devices. Ann Ital Chir (2015) 0.75
Resident training in urology: bipolar transurethral resection of the prostate - a safe method in learning endoscopic surgical procedure. Arch Ital Urol Androl (2013) 0.75
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. J Cancer Res Clin Oncol (2005) 0.75
The Mayer-Rokitansky-Küstner-Hauser syndrome. Arch Ital Urol Androl (2007) 0.75
Computation of the excess glucose and Na deficit of hypo-osmolar hyponatremic hyperglycaemia. Acta Diabetol (2009) 0.75
A malignant fibroleiomyoma of the testis. Clin Lymphoma Myeloma (2006) 0.75
[Ultrasonographic assessment of bladder volume]. Arch Ital Urol Androl (2002) 0.75
Uncommon complication of endoscopic ureterolithotripsy: the stone granuloma. Int J Urol (2006) 0.75
[Percutaneous treatment of varicocele: considerations and our experience]. Arch Ital Urol Androl (2002) 0.75